Table 2. a. Chromosomal regions linked to MS with LOD scores ≥ 1.2 based on multipoint linkage analyses.
Marker region | Distance from p-ter (cM)a | Chromosomal location | Maximum LODb |
---|---|---|---|
D2S1360 | 38 | 2p24.2 | 1.2 |
D2S1328 | 133 | 2q14.3 | 1.3 |
D5S2845 | 36 | 5p14.3 | 1.5 |
D7S2212-D7S821/ GATA5D08 | 95-109 | 7q21.11-7q21.3 | 3.6 |
D8S1136/GATA41A01 | 82 | 8q13.1 | 2.6 |
D11S1999 | 17 | 11p15.4 | 2.3 |
D13S1265-D13S285 | 99-111 | 13q33.3-13q34 | 1.6 |
aMarshfield data (Kosambi cM) | |||
bMS adjusted for covariate effects of age |
b. Evidence for linkage of the five dichotomous MS risk factors as defined by NCEP/ATPIII criteria and the corresponding quantitative traits on chromosome 7q | ||
---|---|---|
Traits (Dichotomous; Quantitative) | Distance from p-ter (cM)a | Maximum LODb |
Abdominal Obesity; WC | 95-109 | 1.45; 1.65 |
High Triglycerides; TG | 95-109 | 0.76; 0.19 |
Low HDL-C; HDL-C | 95-109 | 1.12; 1.36 |
High fasting glucose; FG | 95-109 | 0.85; 0.22 |
High blood pressure; SBP and DBP | 95-109 | 0.43; 0.05 and 0.54 |
Marshfield data (Kosambi cM)
all dichotomous traits adjusted for covariate effects of age as in the case of original linkage analysis (Table 2a); quantitative traits were adjusted for age and sex terms as well as for medication status for TG, HDL-C, FG, SBP and DBP